Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Pollard

Showing results (841-850 of 992) with videos related to

Pageof 100
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|April 27, 2026
Evaluation of Salmonella Paratyphi specific antibody quantity and function after vaccination and controlled human infectionElizabeth Jones, Anna Beekmayer-Dhillon, Nicole Day, et al.
The New England Journal of Medicine|December 5, 2019
Phase 3 Efficacy Analysis of a Typhoid Conjugate Vaccine Trial in NepalMila Shakya, Rachel Colin-Jones, Katherine Theiss-Nyland, et al.
Cancer Genetics and Cytogenetics|May 28, 2008
Mutation screening of fumarate hydratase by multiplex ligation-dependent probe amplification: detection of exonic deletion in a patient with leiomyomatosis and renal cell cancerTaru Ahvenainen, Heli J Lehtonen, Rainer Lehtonen, et al.
BMJ Open|July 5, 2017
The STRATAA study protocol: a programme to assess the burden of enteric fever in Bangladesh, Malawi and Nepal using prospective population census, passive surveillance, serological studies and healthcare utilisation surveysThomas C Darton, James E Meiring, Susan Tonks, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 24, 2012
H1N1 antibody persistence 1 year after immunization with an adjuvanted or whole-virion pandemic vaccine and immunogenicity and reactogenicity of subsequent seasonal influenza vaccine: a multicenter follow-on studyWoolf T Walker, Philip de Whalley, Nick Andrews, et al.
The Pediatric Infectious Disease Journal|December 15, 2010
Immunogenicity and reactogenicity of a 13-valent-pneumococcal conjugate vaccine administered at 2, 4, and 12 months of age: a double-blind randomized active-controlled trialMatthew D Snape, Chaam L Klinger, Elvis D Daniels, et al.
Nature Communications|March 17, 2024
Targeted metagenomics reveals association between severity and pathogen co-detection in infants with respiratory syncytial virusGu-Lung Lin, Simon B Drysdale, Matthew D Snape, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 12, 2022
Prevention of Typhoid by Vi Conjugate Vaccine and Achievable Improvements in Household Water, Sanitation, and Hygiene: Evidence From a Cluster-Randomized Trial in Dhaka, BangladeshBirkneh Tilahun Tadesse, Farhana Khanam, Faisal Ahmmed, et al.
Science Translational Medicine|May 7, 2025
A phase 1/2a clinical trial to assess safety and immunogenicity of an adenoviral-vectored capsular group B meningococcal vaccineChristina Dold, Blanché Oguti, Laura Silva-Reyes, et al.
BMJ (Clinical Research Ed.)|May 29, 2010
Safety and immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label, randomised, parallel group, multicentre studyClaire S Waddington, W T Walker, C Oeser, et al.
Pageof 100

Showing results (841-850 of 992) with videos related to

Sort By:
Pageof 100
Journal of Immunology (Baltimore, Md. : 1950)|April 27, 2026
Evaluation of Salmonella Paratyphi specific antibody quantity and function after vaccination and controlled human infectionElizabeth Jones, Anna Beekmayer-Dhillon, Nicole Day, et al.
The New England Journal of Medicine|December 5, 2019
Phase 3 Efficacy Analysis of a Typhoid Conjugate Vaccine Trial in NepalMila Shakya, Rachel Colin-Jones, Katherine Theiss-Nyland, et al.
Cancer Genetics and Cytogenetics|May 28, 2008
Mutation screening of fumarate hydratase by multiplex ligation-dependent probe amplification: detection of exonic deletion in a patient with leiomyomatosis and renal cell cancerTaru Ahvenainen, Heli J Lehtonen, Rainer Lehtonen, et al.
BMJ Open|July 5, 2017
The STRATAA study protocol: a programme to assess the burden of enteric fever in Bangladesh, Malawi and Nepal using prospective population census, passive surveillance, serological studies and healthcare utilisation surveysThomas C Darton, James E Meiring, Susan Tonks, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 24, 2012
H1N1 antibody persistence 1 year after immunization with an adjuvanted or whole-virion pandemic vaccine and immunogenicity and reactogenicity of subsequent seasonal influenza vaccine: a multicenter follow-on studyWoolf T Walker, Philip de Whalley, Nick Andrews, et al.
The Pediatric Infectious Disease Journal|December 15, 2010
Immunogenicity and reactogenicity of a 13-valent-pneumococcal conjugate vaccine administered at 2, 4, and 12 months of age: a double-blind randomized active-controlled trialMatthew D Snape, Chaam L Klinger, Elvis D Daniels, et al.
Nature Communications|March 17, 2024
Targeted metagenomics reveals association between severity and pathogen co-detection in infants with respiratory syncytial virusGu-Lung Lin, Simon B Drysdale, Matthew D Snape, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 12, 2022
Prevention of Typhoid by Vi Conjugate Vaccine and Achievable Improvements in Household Water, Sanitation, and Hygiene: Evidence From a Cluster-Randomized Trial in Dhaka, BangladeshBirkneh Tilahun Tadesse, Farhana Khanam, Faisal Ahmmed, et al.
Science Translational Medicine|May 7, 2025
A phase 1/2a clinical trial to assess safety and immunogenicity of an adenoviral-vectored capsular group B meningococcal vaccineChristina Dold, Blanché Oguti, Laura Silva-Reyes, et al.
BMJ (Clinical Research Ed.)|May 29, 2010
Safety and immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label, randomised, parallel group, multicentre studyClaire S Waddington, W T Walker, C Oeser, et al.
Pageof 100